Read More
C-Path awarded FDA grant to establish Rare Disease Clinical Outcome Assessment Consortium
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
- COVID isolation and quarantine period for general population shortened by CDC
- Structural blueprint of nanoparticles developed to target neutrophils responsible for acute lung inflammation
- Study hints subtle differences in the quality of immune response based on COVID-19 severity
- High-fiber diet helps melanoma patients to respond better to immunotherapy
Subscribe to:
Post Comments (Atom)
0 Response to "C-Path awarded FDA grant to establish Rare Disease Clinical Outcome Assessment Consortium"
Post a Comment